Gaidai reliability method for long-term coronavirus modelling.

Oleg Gaidai, Ping Yan, Yihan Xing, JingXiang Xu, Yu Wu
Author Information
  1. Oleg Gaidai: Engineering Research Center of Marine Renewable Energy, Shanghai Ocean University, Shanghai, China. ORCID
  2. Ping Yan: Engineering Research Center of Marine Renewable Energy, Shanghai Ocean University, Shanghai, China.
  3. Yihan Xing: Department of Mechanical and Structural Engineering and Materials Science, University of Stavanger, Stavanger, Norway. ORCID
  4. JingXiang Xu: Engineering Research Center of Marine Renewable Energy, Shanghai Ocean University, Shanghai, China.
  5. Yu Wu: Engineering Research Center of Marine Renewable Energy, Shanghai Ocean University, Shanghai, China.

Abstract

Background: Novel coronavirus disease has been recently a concern for worldwide public health. To determine epidemic rate probability at any time in any region of interest, one needs efficient bio-system reliability approach, particularly suitable for multi-regional environmental and health systems, observed over a sufficient period of time, resulting in a reliable long-term forecast of novel coronavirus infection rate. Traditional statistical methods dealing with temporal observations of multi-regional processes do not have the multi-dimensionality advantage, that suggested methodology offers, namely dealing efficiently with multiple regions at the same time and accounting for cross-correlations between different regional observations.
Methods: Modern multi-dimensional novel statistical method was directly applied to raw clinical data, able to deal with territorial mapping. Novel reliability method based on statistical extreme value theory has been suggested to deal with challenging epidemic forecast. Authors used MATLAB optimization software.
Results: This paper described a novel bio-system reliability approach, particularly suitable for multi-country environmental and health systems, observed over a sufficient period of time, resulting in a reliable long-term forecast of extreme novel coronavirus death rate probability. Namely, accurate maximum recorded patient numbers are predicted for the years to come for the analyzed provinces.
Conclusions: The suggested method performed well by supplying not only an estimate but 95% confidence interval as well. Note that suggested methodology is not limited to any specific epidemics or any specific terrain, namely its truly general. The only assumption and limitation is bio-system stationarity, alternatively trend analysis should be performed first. The suggested methodology can be used in various public health applications, based on their clinical survey data.

Keywords

References

  1. Lancet. 2020 Feb 22;395(10224):565-574 [PMID: 32007145]
  2. Nat Med. 2021 Apr;27(4):626-631 [PMID: 33692530]
  3. N Engl J Med. 2020 Feb 20;382(8):727-733 [PMID: 31978945]
  4. J Med Virol. 2020 Jul;92(7):719-725 [PMID: 32170865]
  5. Sci Rep. 2023 Mar 22;13(1):4695 [PMID: 36949113]
  6. Environ Health Prev Med. 2012 Mar;17(2):98-108 [PMID: 21647571]
  7. Stat Med. 2020 Sep 30;39(22):2962-2979 [PMID: 32678481]
  8. Sci Rep. 2023 Mar 7;13(1):3817 [PMID: 36882439]
  9. Lancet. 2020 Feb 29;395(10225):689-697 [PMID: 32014114]
  10. Cancer Innov. 2023 Feb 09;2(2):140-147 [PMID: 38090058]
  11. Digit Health. 2023 Mar 14;9:20552076231162984 [PMID: 36937694]
  12. Accid Anal Prev. 2006 Jul;38(4):811-22 [PMID: 16546103]
  13. J Hyg (Lond). 1954 Sep;52(3):400-2 [PMID: 13212043]
  14. JAMA. 2020 Apr 7;323(13):1239-1242 [PMID: 32091533]
  15. Nature. 2020 Mar;579(7798):270-273 [PMID: 32015507]
  16. Accid Anal Prev. 2014 Jan;62:32-41 [PMID: 24129319]
  17. PLoS One. 2010 Mar 01;5(3):e9450 [PMID: 20209164]
  18. Sci Rep. 2023 Jan 20;13(1):1119 [PMID: 36670233]
  19. Bioinform Biol Insights. 2023 Apr 11;17:11779322231161939 [PMID: 37065993]
  20. BMC Psychiatry. 2023 Sep 22;23(1):691 [PMID: 37736716]
  21. Micromachines (Basel). 2023 Jan 20;14(2): [PMID: 36837974]
  22. Sci Rep. 2023 Sep 28;13(1):16312 [PMID: 37770505]
  23. Theor Popul Biol. 2018 Jul;122:88-96 [PMID: 28709927]
  24. Sci Rep. 2022 Dec 7;12(1):21182 [PMID: 36476650]
  25. PLoS One. 2015 Feb 24;10(2):e0118521 [PMID: 25710503]
  26. Biosystems. 2023 Nov;233:105035 [PMID: 37739309]
  27. Stat Med. 2002 Sep 30;21(18):2703-21 [PMID: 12228886]
  28. PLoS One. 2021 Mar 25;16(3):e0249037 [PMID: 33765088]
  29. Curr Probl Cardiol. 2023 May;48(5):101622 [PMID: 36724816]
  30. Biosystems. 2024 Jan;235:105073 [PMID: 37967809]
  31. Heliyon. 2023 Feb 06;9(2):e13533 [PMID: 36825173]
  32. PLoS One. 2013 Jul 24;8(7):e69305 [PMID: 23894447]
  33. JAMA. 2020 Apr 21;323(15):1502-1503 [PMID: 32105304]
  34. PLoS Med. 2011 Jul;8(7):e1001051 [PMID: 21750666]
  35. Heliyon. 2023 Apr 05;9(4):e15189 [PMID: 37101618]

MeSH Term

Humans
Reproducibility of Results
Epidemics
SARS-CoV-2